• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

如何更有效地、方便地和灵活地应用 FMT——FMT 方法的比较。

How to Apply FMT More Effectively, Conveniently and Flexible - A Comparison of FMT Methods.

机构信息

Department of Medical Microbiology and Immunology, University of Pécs Clinical Centre, Pécs, Hungary.

1stDepartment of Internal Medicine - Department of Infectology, University of Pécs Clinical Centre, Pécs, Hungary.

出版信息

Front Cell Infect Microbiol. 2021 Jun 4;11:657320. doi: 10.3389/fcimb.2021.657320. eCollection 2021.

DOI:10.3389/fcimb.2021.657320
PMID:34150673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8213398/
Abstract

PURPOSE

Metronidazol and vancomycin were long the two best options against (formerly ) infections (CDI). Now, the cost of new drugs such as fidaxomicin directs us towards alternative treatment options, such as faecal microbiota transplant (FMT). Its effectiveness is similar to fidaxomicin. There are questions regarding its safety, but the biggest challenges are prejudice and inconvenience. Most protocols refer to FMT applied in the form of a solution. We investigated different modalities of FMT.

METHODS

Instead of using nasoenteric tubes or colonoscopy, we place frozen or lyophilised stool in non-coated, size "00", hard gelatine capsules or enterosolvent, size "0" capsules.

RESULTS

We found that non-coated, size "00", hard gelatine capsules are appropriate for conducting FMT. Capsules containing lyophilised supernatant with a low number of bacteria have been proven to be non-inferior to other FMT modalities. The primary cure rate in the supernatant group was 93.75%, and 66.67% in the sediment group. The overall cure rate was 82.14%. Depending on the protocol, 4-7 capsules are sufficient per patient. Capsules can be stored for up to one year at -20°C.

CONCLUSIONS

FMT is a feasible alternative to antibiotic treatments in CDI. Our method makes the process flexible and less inconvenient to patients. Long storage time allows a consistent supply of capsules, while small volume and formulation make the procedure tolerable.

摘要

目的

甲硝唑和万古霉素长期以来一直是治疗 (前) 感染(CDI)的两种最佳选择。现在,像非达霉素这样的新药的成本促使我们转向替代治疗方案,如粪便微生物群移植(FMT)。它的有效性与非达霉素相似。关于其安全性存在一些问题,但最大的挑战是偏见和不便。大多数方案都提到了以溶液形式应用的 FMT。我们调查了 FMT 的不同方式。

方法

我们没有使用鼻肠管或结肠镜检查,而是将冷冻或冻干的粪便放入无涂层、大小为“00”的硬明胶胶囊或肠溶、大小为“0”的胶囊中。

结果

我们发现无涂层、大小为“00”的硬明胶胶囊适合进行 FMT。含有细菌数量低的冻干上清液的胶囊已被证明与其他 FMT 方式一样有效。上清液组的主要治愈率为 93.75%,沉淀物组为 66.67%。总体治愈率为 82.14%。根据方案,每个患者需要 4-7 个胶囊。胶囊可在-20°C 下储存长达一年。

结论

FMT 是 CDI 抗生素治疗的可行替代方案。我们的方法使该过程对患者更灵活且不便。较长的储存时间允许持续供应胶囊,而较小的体积和配方使该过程更耐受。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f92a/8213398/e2b6fc905cb9/fcimb-11-657320-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f92a/8213398/454346557a95/fcimb-11-657320-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f92a/8213398/8c56f9d20bc0/fcimb-11-657320-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f92a/8213398/3fae32118bda/fcimb-11-657320-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f92a/8213398/e2b6fc905cb9/fcimb-11-657320-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f92a/8213398/454346557a95/fcimb-11-657320-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f92a/8213398/8c56f9d20bc0/fcimb-11-657320-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f92a/8213398/3fae32118bda/fcimb-11-657320-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f92a/8213398/e2b6fc905cb9/fcimb-11-657320-g004.jpg

相似文献

1
How to Apply FMT More Effectively, Conveniently and Flexible - A Comparison of FMT Methods.如何更有效地、方便地和灵活地应用 FMT——FMT 方法的比较。
Front Cell Infect Microbiol. 2021 Jun 4;11:657320. doi: 10.3389/fcimb.2021.657320. eCollection 2021.
2
Efficacy of lyophilised bacteria-rich faecal sediment and supernatant with reduced bacterial count for treating patients with Infection - A novel method for capsule faecal microbiota transfer.富含细菌的冻干粪便沉淀物和上清液(细菌计数减少)治疗感染患者的疗效-胶囊粪便微生物群转移的新方法。
Front Cell Infect Microbiol. 2023 Jan 23;13:1041384. doi: 10.3389/fcimb.2023.1041384. eCollection 2023.
3
Fecal Transplants by Colonoscopy and Capsules Are Cost-Effective Strategies for Treating Recurrent Clostridioides difficile Infection.通过结肠镜检查和胶囊进行粪便移植是治疗复发性艰难梭菌感染的具有成本效益的策略。
Dig Dis Sci. 2020 Apr;65(4):1125-1133. doi: 10.1007/s10620-019-05821-1. Epub 2019 Sep 6.
4
Cost-effectiveness analysis of a fecal microbiota transplant center for treating recurrent C.difficile infection.治疗复发性艰难梭菌感染的粪便微生物移植中心的成本效益分析。
J Infect. 2020 Nov;81(5):758-765. doi: 10.1016/j.jinf.2020.09.025. Epub 2020 Sep 24.
5
Faecal microbiota transplantation for recurrent Clostridioides difficile infection: experience with lyophilized oral capsules.粪便微生物群移植治疗复发性艰难梭菌感染:冻干口服胶囊的经验。
J Hosp Infect. 2020 Jun;105(2):319-324. doi: 10.1016/j.jhin.2019.12.022. Epub 2019 Dec 26.
6
Design and manufacture of a lyophilised faecal microbiota capsule formulation to GMP standards.按照 GMP 标准设计和制造冻干粪便微生物胶囊配方。
J Control Release. 2022 Oct;350:324-331. doi: 10.1016/j.jconrel.2022.08.012. Epub 2022 Aug 26.
7
Fecal Microbiota Transplantation (FMT) with Colonoscopy Is Superior to Enema and Nasogastric Tube While Comparable to Capsule for the Treatment of Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-Analysis.经结肠镜检查的粪便微生物移植(FMT)优于灌肠和鼻胃管,与胶囊治疗复发性艰难梭菌感染相当:系统评价和荟萃分析。
Dig Dis Sci. 2021 Feb;66(2):369-380. doi: 10.1007/s10620-020-06185-7. Epub 2020 Mar 12.
8
[Reconsidering the technical aspects and quality management background of faecal microbiota transplantation due to the novel coronavirus pandemic].[鉴于新型冠状病毒大流行重新审视粪便微生物群移植的技术方面和质量管理背景]
Orv Hetil. 2020 Nov 1;161(44):1858-1871. doi: 10.1556/650.2020.32023.
9
Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection.用于复发性艰难梭菌感染的口服、冷冻粪便微生物群移植(FMT)胶囊。
BMC Med. 2016 Sep 9;14(1):134. doi: 10.1186/s12916-016-0680-9.
10
Faecal microbiota transplantation as a home therapy to frail older people.粪便微生物群移植作为体弱老年人的居家疗法。
Age Ageing. 2020 Oct 23;49(6):1093-1096. doi: 10.1093/ageing/afaa073.

引用本文的文献

1
Gut Microbiota Modulation in IBD: From the Old Paradigm to Revolutionary Tools.炎症性肠病中的肠道微生物群调节:从旧范式到革命性工具
Int J Mol Sci. 2025 Mar 27;26(7):3059. doi: 10.3390/ijms26073059.
2
Fecal microbiota transplantation for the treatment of intestinal and extra-intestinal diseases: Mechanism basis, clinical application, and potential prospect.粪便微生物群移植治疗肠道和肠道外疾病:机制基础、临床应用及潜在前景。
Bioeng Transl Med. 2024 Nov 7;10(2):e10728. doi: 10.1002/btm2.10728. eCollection 2025 Mar.
3
In vitro validation concept for lyophilized fecal microbiota products with a focus on bacterial viability.

本文引用的文献

1
Mechanisms underpinning the efficacy of faecal microbiota transplantation in treating gastrointestinal disease.粪菌移植治疗胃肠道疾病疗效的潜在机制。
Therap Adv Gastroenterol. 2020 Sep 3;13:1756284820946904. doi: 10.1177/1756284820946904. eCollection 2020.
2
Trends in U.S. Burden of Infection and Outcomes.美国感染负担和结局的趋势。
N Engl J Med. 2020 Apr 2;382(14):1320-1330. doi: 10.1056/NEJMoa1910215.
3
Expert opinion on fecal microbiota transplantation for the treatment of infection and beyond.专家意见:粪便微生物群移植治疗感染及其他相关疾病。
以细菌活力为重点的冻干粪便微生物群产品的体外验证概念。
World J Microbiol Biotechnol. 2025 Feb 27;41(3):83. doi: 10.1007/s11274-025-04291-0.
4
Validation methods for encapsulated faecal microbiota transplantation: a scoping review.胶囊化粪菌移植的验证方法:一项范围综述
Therap Adv Gastroenterol. 2025 Feb 8;18:17562848251314820. doi: 10.1177/17562848251314820. eCollection 2025.
5
Management of Recurrent Clostridioides difficile Infection (rCDI): A Systematic Literature Review to Assess the Feasibility of Indirect Treatment Comparison (ITC).复发性艰难梭菌感染(rCDI)的管理:一项评估间接治疗比较(ITC)可行性的系统文献综述
Infect Dis Ther. 2025 Feb;14(2):327-355. doi: 10.1007/s40121-024-01105-y. Epub 2025 Jan 16.
6
Evaluating Bacterial Viability in Faecal Microbiota Transplantation: A Comparative Analysis of In Vitro Cultivation and Membrane Integrity Methods.评估粪便微生物群移植中的细菌活力:体外培养与膜完整性方法的比较分析。
J Clin Lab Anal. 2024 Oct;38(19-20):e25105. doi: 10.1002/jcla.25105. Epub 2024 Oct 3.
7
Encapsulation protocol for fecal microbiota transplantation.粪便微生物群移植的封装方案。
Front Cell Infect Microbiol. 2024 Jun 26;14:1424376. doi: 10.3389/fcimb.2024.1424376. eCollection 2024.
8
Short-Chain Fatty Acids and Human Health: From Metabolic Pathways to Current Therapeutic Implications.短链脂肪酸与人类健康:从代谢途径到当前的治疗意义
Life (Basel). 2024 Apr 26;14(5):559. doi: 10.3390/life14050559.
9
Alternative treatment of recurrent infection in adults by fecal transplantation: an overview of phase I-IV studies from Clinicaltrials.gov.粪便移植对成人复发性感染的替代治疗:来自Clinicaltrials.gov的I-IV期研究综述
Front Microbiol. 2024 May 9;15:1374774. doi: 10.3389/fmicb.2024.1374774. eCollection 2024.
10
Novel approaches in IBD therapy: targeting the gut microbiota-bile acid axis.IBD 治疗的新方法:靶向肠道微生物群-胆汁酸轴。
Gut Microbes. 2024 Jan-Dec;16(1):2356284. doi: 10.1080/19490976.2024.2356284. Epub 2024 May 20.
Expert Opin Biol Ther. 2020 Jan;20(1):73-81. doi: 10.1080/14712598.2020.1689952. Epub 2019 Nov 13.
4
Fidaxomicin compared with vancomycin and metronidazole for the treatment of Clostridioides (Clostridium) difficile infection: A network meta-analysis.非达霉素与万古霉素和甲硝唑治疗艰难梭菌感染的比较:一项网状Meta分析。
J Infect Chemother. 2020 Jan;26(1):43-50. doi: 10.1016/j.jiac.2019.07.005. Epub 2019 Oct 14.
5
The effect of probiotics on the incidence of Clostridioides difficile: Retrospective cohort analysis.益生菌对艰难梭菌感染发生率的影响:回顾性队列分析。
Am J Infect Control. 2020 Feb;48(2):184-188. doi: 10.1016/j.ajic.2019.07.026. Epub 2019 Oct 10.
6
Clostridioides difficile infection and recurrence among 2622 solid organ transplant recipients.2622例实体器官移植受者中的艰难梭菌感染及复发情况
Transpl Infect Dis. 2019 Dec;21(6):e13184. doi: 10.1111/tid.13184. Epub 2019 Oct 11.
7
Microbiota modulation-based therapy for luminal GI disorders: current applications of probiotics and fecal microbiota transplantation.基于肠道菌群调节的腔道 GI 疾病治疗:益生菌和粪便微生物群移植的当前应用。
Expert Opin Biol Ther. 2019 Dec;19(12):1343-1355. doi: 10.1080/14712598.2019.1673725. Epub 2019 Oct 13.
8
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice.国际共识会议关于粪便银行在临床实践中进行粪便微生物群移植。
Gut. 2019 Dec;68(12):2111-2121. doi: 10.1136/gutjnl-2019-319548. Epub 2019 Sep 28.
9
Prevention of recurrent Clostridioides difficile infection: A systematic review of randomized controlled trials.预防复发性艰难梭菌感染:随机对照试验的系统评价。
Anaerobe. 2020 Feb;61:102098. doi: 10.1016/j.anaerobe.2019.102098. Epub 2019 Sep 4.
10
therapeutics: guidelines and beyond.治疗学:指南及其他
Ther Adv Infect Dis. 2019 Aug 13;6:2049936119868548. doi: 10.1177/2049936119868548. eCollection 2019 Jan-Dec.